Screening and review of literature search results (articles/abstracts/citations) for purposes of ICSR identification or Triaging literature search results for potential articles of interest with relevant safety information
Provide support for Central Safety Department (CSD) literature screening activities for both ICSR and signal detection purposes in accordance with their procedures and regulatory requirements.
Enter information into PVG quality and tracking systems for receipt and tracking ICSR.
• Assist in the processing of ICSRs according to Standard Operating Procedures (SOPs) and project/program-specific safety plans.
- Triages ICSRs, evaluates ICSR data for completeness, accuracy, and regulatory report ability.
- Enters data into safety database.
- Codes events, medical history, concomitant medications and tests.
- Compiles complete narrative summaries.
- Identifies information to be queried and follows up until information is obtained and queries are satisfactorily resolved.
- Assists in the generation of timely, consistent and accurate reporting of expedited reports in accordance with applicable regulatory requirements.
• Ensures all relevant documents are submitted to the Trial Master File (TMF) as per company SOP/Sponsor requirements for clinical trials and the Pharmacovigilance System Master File for post-marketing programs as appropriate.
• Maintains understanding and compliance with SOPs, Work Instructions (WIs), global drug/biologic/device regulations, GCPs, ICH guidelines, GVP, project/program plans and the
drug development process.
Creation of variations in the regulatory database to track labeling, quality or administrative changes, creation of references for responses to health authority regarding PSUSA or PBRER, Referrals etc. in the European Union region for National, Centralized, Mutual Recognition and Decentralized procedures.
• Maintaining a good working knowledge of the adverse event safety profile of the assigned drugs, labeling doc and SOPs, and Global drug safety regulations.
• work to ensure compliance with internal and regulatory timelines for the adverse event reporting.
• Assist in development of project specific safety procedures, workflows and templates.
• Attend internal, drug safety and project specific training sessions.
• Completes trainings assigned on internal and client Learning Management System (LMS) as applicable.
• Preparation for, participation in, and follow up on audits and inspections.
• Monitoring of incoming reports from various sources viz mailboxes, EudraVigilance, literature searches etc.
• Perform literature searches as per search strategy, performs data entry of valid cases into the safety database.
• Triage of incoming reports for completeness, legibility and validity, including literature abstracts/articles/citations.
• Responsible for sending translation requests if any.
• Perform a check on overall medical cohesiveness and consistency of the document.
• Compares and analyses data provided by the affiliate with the data available on client application.
• Prepares ADR form/coversheet as required.
• Addition of new products/deletion of products withdrawn from the market/expired license/MAH transferred products on the client application tool.
• Creates the case on the safety database.
• Performs clear and accurate data capture of cases in accordance with client conventions/guidelines and Standard Operating Procedures (SOPs).
• Ensures that the expectedness, causality assessment and seriousness criteria are accurate for the event.
• Ensures MedDRA coding in accordance with "MedDRA Term selection: Points to Consider"
• Request follow-up and perform query management, as applicable.
• Prepares medically cohesive case narratives based upon the reported information.
• Routes the case to the next workflow state as applicable in the safety database.
• Performs quality checks/validation checks in reference to standardized QC checklist and document the errors accordingly
• Supports compliance activities for ICSRs including late case investigation of ICSRs to various Health Authorities and Business Partners to determine the assignable cause for lateness and collection of lateness documentation including corrective actions, where applicable.
1. Chopra, N. 2014, A research article on 3D QSAR Studies on Pyridopyrimidines as selective p- glycoprotein antagonist, international journal of pharmacy and pharmaceutical sciences vol. 6 (8), 232-239. ISSN- 0975-1491.
2. Chopra, N. 2014, A review article on various biological activities of Thiadiazol published in international journal of pharmacy and pharmaceutical sciences vol.7(4). ISSN- 0975-1491.
3. Chopra, N. 2018, A research article on "Synthesis, Molecular docking and Antimicrobial Evaluation of new
Tetrahydrobenzothienopyrimidine Derivatives" published in International Journal of Trend in Scientific Research and Development, volume 2 (6). ISSN 2456-6470.
4. Chopra, N. A research article on "Assessment of Antimicrobial, Anti-inflammatory activity and Docking study of novel 2-(arylimino)-5-(indole-2-yl-methylidene)-1,3-thiazolidine-4-one derivatives" published in International Journal of Trend in Scientific Research and Development, volume 2 (6) ISSN 2456-6470
5. Chopra, N. 2018, A research article on “Synthesis, antimicrobial and anticorrosive evaluation of 1H- benzo[d]imidazol-2-yl)-Nsubstituted- benzylidenemethanamine analogs” Published in The Indian Journal of Pharmaceutical Sciences, ISNN 0250474X
6. Chopra, N. 2019, A research article entitled “Synthesis, Characterization and antimicrobial evaluation of heterocyclic conjugates by Knoevenagel condensation in International Journal of Pharmaceutical Sciences and Research (IJPSR), ISSN 2320-5148
7. Chopra, N. 2019, Research article on “In vitro cytotoxic Study of electron donating Substituent’s on Thiazolidinone scaffold bearing thiadiazole ring against MCF-7 and HeLa cell lines” published in Journal of heterocyclic Chemistry (JHET), ISNN 0022-152X
8 Chopra, N. 2020, Research article on “Synthesis, Characterization and In vitro anticancer evaluation of
4-(5-(2-(substituted)-4-oxothiazolidin-3-yl)-1,3,4-thiadiazol-2-yl)-phenyl-acetate derived from Phenolic aldehyde in Plant archives vol 20, issue 2, ISNN number 09725210.
9. Chopra, N. 2020, Research article on Comparative In vitro anticancer study of 4-Thiazolidinone scaffold bearing Thiadiazole moiety derived from Phenolic aldehydes is published in international journal of Pharmaceutical Research (IJPR) with ISNN number 0975-2366.
10. A textbook on Organic Chemistry II for Pharmacy 3rd Semester published by Akinik publications, ISBN no 978-93-5570-467-2
11. A textbook on Medicinal Chemistry for 5th Semester published by Akinik Publisher ISBN 978-93-90420-99
13. A text book of Polymer-Drug conjugates: Linker Chemistry Published by Elseveir ISBN no 9780323916639